梁 凡, 陈亚萍, 杨 恭. Advances in cancer stromal cells and their association with ovarian cancer therapy[J]. China Oncology, 2016, 26(4): 351-357. DOI: 10.3969/j.issn.1007-3969.2016.04.011.
Advances in cancer stromal cells and their association with ovarian cancer therapy
Ovarian cancer bears the highest mortality in gynecologic cancer
and its 5-year survival rate is about 30%. Although 70% to 80% ovarian cancer is epithelial origin
increasing evidence indicates that reciprocal interactions between tumor cells and various types of stromal cells also play important roles in driving ovarian tumor progression and that these stromal cells represent attractive therapeutic targets. This review discusses the biological significance of the cross-talk between ovarian cancer cells and three major types of stromal cells (endothelial cells
fibroblasts and macrophages) and the development of new-generation therapies that target the ovarian tumor microenvironment.
Transforming growth factor beta-1 promotes migration and invasion of ovarian epithelial carcinoma cells through TRAF6-mediated activation of Notch3 signaling pathway
Research on the relationship between fructose-1, 6-bisphosphatase and chemosensitivity of ovarian carcinoma